Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2019, Article ID 2494057, 9 pages
https://doi.org/10.1155/2019/2494057
Research Article

The Association between Genomic DNA Methylation and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus

1Department of Endocrinology, The Second Affiliated Hospital, Soochow University, Suzhou 215004, China
2Department of Endocrinology, Suzhou Science and Technology Town Hospital, Nanjing Medical University, Suzhou 215004, China
3Clinical Pharmacology Laboratory, The Second Affiliated Hospital, Soochow University, Suzhou 215004, China

Correspondence should be addressed to Meng Wang; moc.361@ztamgine and Ji Hu; nc.ude.adus@ijuh

Received 14 May 2019; Accepted 12 August 2019; Published 3 November 2019

Academic Editor: Ferdinando Carlo Sasso

Copyright © 2019 Hong-Hong Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Danaei, M. M. Finucane, Y. Lu et al., “National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants,” The Lancet, vol. 378, no. 9785, pp. 31–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Wang, P. Gao, M. Zhang et al., “Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013,” JAMA, vol. 317, no. 24, pp. 2515–2523, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Katulanda, P. Ranasinghe, R. Jayawardena, G. R. Constantine, M. H. R. Sheriff, and D. R. Matthews, “The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country,” Diabetology & Metabolic Syndrome, vol. 4, no. 1, p. 21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Binns-Hall, D. Selvarajah, D. Sanger, J. Walker, A. Scott, and S. Tesfaye, “One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot,” Diabetic Medicine, vol. 35, no. 7, pp. 887–894, 2018. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Reik, W. Dean, and J. Walter, “Epigenetic reprogramming in mammalian development,” Science, vol. 293, no. 5532, pp. 1089–1093, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. B. E. Bernstein, A. Meissner, and E. S. Lander, “The mammalian epigenome,” Cell, vol. 128, no. 4, pp. 669–681, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Anastasiadi, A. Esteve-Codina, and F. Piferrer, “Consistent inverse correlation between DNA methylation of the first intron and gene expression across tissues and species,” Epigenetics & Chromatin, vol. 11, no. 1, p. 37, 2018. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Bansal and S. E. Pinney, “DNA methylation and its role in the pathogenesis of diabetes,” Pediatric Diabetes, vol. 18, no. 3, pp. 167–177, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Agardh, A. Lundstig, A. Perfilyev et al., “Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy,” BMC Medicine, vol. 13, no. 1, p. 182, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Bril and B. A. Perkins, “Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy,” Diabetes Care, vol. 25, no. 11, pp. 2048–2052, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. H. H. Zhang, J. Hu, Y. L. Zhou et al., “Promoted interaction of nuclear factor-κB with demethylated purinergic P2X3 receptor gene contributes to neuropathic pain in rats with diabetes,” Diabetes, vol. 64, no. 12, pp. 4272–4284, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. Won, H. S. Kwon, C. H. Kim et al., “Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with type 2 diabetes in Korea,” Diabetic Medicine, vol. 29, no. 9, pp. e290–e296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Amin and J. Doupis, “Diabetic foot disease: from the evaluation of the “foot at risk” to the novel diabetic ulcer treatment modalities,” World Journal of Diabetes, vol. 7, no. 7, pp. 153–164, 2016. View at Publisher · View at Google Scholar
  14. Y. W. Pai, C. H. Lin, I. T. Lee, and M. H. Chang, “Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 12, no. 2, pp. 111–116, 2018. View at Publisher · View at Google Scholar · View at Scopus
  15. E. L. Feldman, “Oxidative stress and diabetic neuropathy: a new understanding of an old problem,” The Journal of Clinical Investigation, vol. 111, no. 4, pp. 431–433, 2003. View at Publisher · View at Google Scholar
  16. L. M. Roman-Pintos, G. Villegas-Rivera, A. D. Rodriguez-Carrizalez, A. G. Miranda-Diaz, and E. G. Cardona-Munoz, “Diabetic polyneuropathy in type 2 diabetes mellitus: inflammation, oxidative stress, and mitochondrial function,” Journal of Diabetes Research, vol. 2016, Article ID 3425617, 16 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. T. J. Tracey, F. J. Steyn, E. J. Wolvetang, and S. T. Ngo, “Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease,” Frontiers in Molecular Neuroscience, vol. 11, p. 10, 2018. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Tsuzura, Y. Ikeda, T. Suehiro et al., “Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes,” Metabolism: Clinical and Experimental, vol. 53, no. 3, pp. 297–302, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. C. P. Yang, C.-C. Lin, C.-I. Li et al., “Cardiovascular risk factors increase the risks of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: the Taiwan Diabetes Study,” Medicine, vol. 94, no. 42, article e1783, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Zychowska, E. Rojewska, B. Przewlocka, and J. Mika, “Mechanisms and pharmacology of diabetic neuropathy – experimental and clinical studies,” Pharmacological Reports, vol. 65, no. 6, pp. 1601–1610, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Hao, L. Hua, X. Fu, X. Zhang, Q. Zou, and Y. Li, “Genome-wide DNA methylation analysis of human peripheral blood reveals susceptibility loci of diabetes-related hearing loss,” Journal of Human Genetics, vol. 63, no. 12, article 507, pp. 1241–1250, 2018. View at Publisher · View at Google Scholar · View at Scopus
  22. H. H. Zhang, J. Hu, Y. L. Zhou et al., “Promoted interaction of nuclear factor-κB with demethylated cystathionine-β-synthetase gene contributes to gastric hypersensitivity in diabetic rats,” The Journal of neuroscience : the official journal of the Society for Neuroscience, vol. 33, no. 21, pp. 9028–9038, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Guo, S. Elzinga, S. Eid et al., “Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus,” Epigenetics, vol. 14, no. 8, pp. 766–779, 2019. View at Publisher · View at Google Scholar
  24. E. J. Barrett, Z. Liu, M. Khamaisi et al., “Diabetic microvascular disease: an Endocrine Society scientific statement,” The Journal of Clinical Endocrinology and Metabolism, vol. 102, no. 12, pp. 4343–4410, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. J. S. Al-Wakeel, D. Hammad, A. Al Suwaida, A. H. Mitwalli, N. A. Memon, and F. Sulimani, “Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic,” Saudi Journal of Kidney Diseases and Transplantation, vol. 20, pp. 77–85, 2009. View at Google Scholar
  26. T. Marumo, S. Yagi, W. Kawarazaki et al., “Diabetes induces aberrant DNA methylation in the proximal tubules of the kidney,” Journal of the American Society of Nephrology, vol. 26, no. 10, pp. 2388–2397, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Ollikainen, K. Ismail, K. Gervin et al., “Genome-wide blood DNA methylation alterations at regulatory elements and heterochromatic regions in monozygotic twins discordant for obesity and liver fat,” Clinical Epigenetics, vol. 7, no. 1, p. 39, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. C. G. Bell, A. E. Teschendorff, V. K. Rakyan, A. P. Maxwell, S. Beck, and D. A. Savage, “Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus,” BMC Medical Genomics, vol. 3, no. 1, p. 33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Nilsson, A. Matte, A. Perfilyev et al., “Epigenetic alterations in human liver from subjects with type 2 diabetes in parallel with reduced folate levels,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 11, pp. E1491–E1501, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. D. K. Yadav, S. Shrestha, K. A. Lillycrop et al., “Vitamin B12 supplementation influences methylation of genes associated with type 2 diabetes and its intermediate traits,” Epigenomics, vol. 10, no. 1, pp. 71–90, 2018. View at Publisher · View at Google Scholar · View at Scopus